NeuroOne Medical Technologies Corp (NMTC)
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
$1.62-2.41%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
QuarterlyIQ Insights · NMTC
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 | Sep 2015 | Sep 2014 | Sep 2013 | Sep 2012 | Sep 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | 10.0 | 9.1 | 3.5 | 2.0 | 0.2 | 0.2 | — | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Total Revenues | 10.0 | 9.1 | 3.5 | 2.0 | 0.2 | 0.2 | — | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cost of Revenues | 4.4 | 4.0 | 2.4 | 1.5 | 0.2 | 0.3 | — | — | — | — | — | — | — | — | — | 0.0 |
| Gross Profit | 5.6 | 5.1 | 1.1 | 0.5 | (0.1) | (0.1) | — | — | — | — | — | — | — | 0.0 | 0.0 | 0.0 |
| Operating Expenses & Income | ||||||||||||||||
| Selling, General & Admin | 7.8 | 7.4 | 7.9 | 6.9 | 7.0 | 6.3 | — | — | — | — | — | — | — | — | — | — |
| R&D Expenses | 5.4 | 5.0 | 5.1 | 6.9 | 4.9 | 3.9 | 2.1 | 1.5 | 0.7 | — | — | — | — | — | — | — |
| Operating Income | (7.6) | (4.2) | (11.9) | (12.0) | (10.0) | (10.2) | (4.9) | (5.8) | (3.1) | — | (0.0) | (0.0) | (0.0) | (0.0) | — | — |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | — | — | — | — | — | 0.0 | — | — | — | — | — | 0.0 | — | — | (0.0) | (0.0) |
| Other Non-Operating Income / Expenses | — | — | — | — | — | — | — | — | — | — | — | — | (0.0) | (0.0) | — | — |
| EBT, Incl. Unusual Items | (7.1) | (3.6) | (12.3) | (11.9) | (10.0) | — | (2.0) | — | — | — | (0.0) | (0.0) | (0.0) | (0.0) | — | — |
| Income Tax Expense | — | — | — | — | — | (0.3) | — | — | — | — | 0.0 | 0.0 | — | — | — | — |
| Earnings from Continuing Operations | — | — | — | — | — | — | — | — | — | — | — | 0.0 | — | — | — | — |
| Net Income | ||||||||||||||||
| Net Income | (7.1) | (3.6) | (12.3) | (11.9) | (10.0) | (9.9) | (13.6) | (6.8) | (5.1) | — | (0.0) | (0.1) | (0.0) | (0.0) | (0.0) | (0.0) |
| Per Share | ||||||||||||||||
| Basic EPS | (0.83) | (0.09) | (0.46) | (0.65) | (0.63) | (0.93) | — | — | — | — | — | — | — | — | — | — |
| Diluted EPS | (0.82) | (0.09) | (0.46) | (0.65) | (0.63) | (0.93) | — | — | — | — | — | — | — | — | — | — |
| Revenue per Share | 1.14 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 8.7 | 40.2 | 26.8 | 18.1 | 16.0 | 10.7 | — | — | — | — | — | — | — | — | 5.1 | 4.6 |
| Diluted Weighted Avg Shares | 8.7 | 40.2 | 26.8 | 18.1 | 16.0 | 10.7 | — | — | — | — | — | — | — | — | — | — |
| Supplemental | ||||||||||||||||
| EBITDA | — | (4.0) | (11.6) | (11.8) | (9.9) | (10.1) | (4.9) | — | — | — | — | — | — | — | — | — |
| EBIT | (7.6) | (4.2) | (11.9) | (12.0) | (10.0) | (10.2) | (4.9) | (5.8) | (3.1) | — | (0.0) | (0.0) | (0.0) | (0.0) | — | — |
| Effective Tax Rate | — | — | — | — | — | 13.4% | — | — | — | — | 0.0% | 0.0% | — | — | — | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.